MedPath

To understand the outcomes of treating children with antibiotic and without antibiotic in uncomplicated upper respiratory tract infection.

Phase 3
Not yet recruiting
Conditions
Acute upper respiratory infection,unspecified,
Registration Number
CTRI/2024/04/065187
Lead Sponsor
Sms medical college
Brief Summary

Majority of upper respiratory tract infection are of viral origin and are often self limiting. Antibiotic prescription in URTI’s are inappropriately very high.Therefore the purpose of the study is to reduce the irrational use of antibiotic in URTI’s in children in india.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
240
Inclusion Criteria
  • 1.presenting at pediatric outdoor with signs and symptoms of upper respiratory tract infection 2.
  • duration of illness less than 3 days 3.
  • provided written consent.
Exclusion Criteria
  • 1.diagnosis of tuberculosis, pneumonia, ARDS 2.
  • any complicated respiratory tract infection requiring admission to indoor department.
  • chronic respiratory illness.
  • 4.reactive airway disease.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
duration of symptoms of upper 1.respiratory tract infection as calculated to the point when symptoms disappearOutcome will be assessed after 48 hours, 7 days and 14 days of intervention.
2.severity of infection as assessed by scoring on a 7 point linkert scaleOutcome will be assessed after 48 hours, 7 days and 14 days of intervention.
Secondary Outcome Measures
NameTimeMethod
1. use of antibiotics during entire coarse of illness2. parental satisfaction assessed on a 6 point linkert scale

Trial Locations

Locations (1)

S.M.S Medical college

🇮🇳

Jaipur, RAJASTHAN, India

S.M.S Medical college
🇮🇳Jaipur, RAJASTHAN, India
Dr Laxmiprasad
Principal investigator
9880066140
laxmiprasadjaguar29@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.